27Jul 2021
Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure

Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure

Histone LSD1 (lysine-specific demethylase 1) is an important epigenetic antitumor drug target, whose inhibitors are currently in phase I/II clinical trials. However, the potential side effects of LSD1 inhibition in the progress of cardiac remodeling to heart failure remain to be investigated...

  • #cardiology

Like

Save

Share